Fingerprint
Dive into the research topics of 'Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Joseph M. Herman, Katherine Y. Fan, Aaron T. Wild, Amy Hacker-Prietz, Laura D. Wood, Amanda L. Blackford, Susannah Ellsworth, Lei Zheng, Dung T. Le, Ana De Jesus-Acosta, Manuel Hidalgo, Ross C. Donehower, Richard D. Schulick, Barish H. Edil, Michael A. Choti, Ralph H. Hruban, Timothy M. Pawlik, John L. Cameron, Daniel A. Laheru, Christopher L. Wolfgang
Research output: Contribution to journal › Article › peer-review